Advertisement

Supply Chain

The 2.3 percent excise tax imposed on medical devices in 2013 as part of the Affordable Care Act significantly reduced R&D investment, sales revenue, gross margins and earnings, according to a study published in Research Policy. 

Advertisement
Advertisement
Advertisement